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Helicobacterpylori is the main pathogenic factor in peptic 
ulcer disease [l-31. It has also been implicated in the 
development of gastric carcinoma and the gastric 
MALT-type lymphoma [4,5]. Treating complications of 
this infection has a high cost. At present, our know- 
ledge of its epidemiology is limited; a more thorough 
understanding would help in the design of appropriate 
strategies for diagnosis and treatment, or in deter- 
mining which candidates should receive vaccination in 
the future. 
Few reports of the prevalence of H. pylori infection 
in Spain have been published. Most of the papers that 
mention the infection provide only indn-ect data, 
from populations submitted to endoscopy [6-81, blood 
donors [9-121, or relatives of patients with peptic ulcer 
[13]. Few studies have been designed to estimate the 
prevalence of the infection in the general population 
[ 1 4,151. 
The objective of our study was to determine the 
prevalence of H. pylori infection in a population sample 
from the Sabadell area, and to analyze its distribution 
according to age, sex and demographic area. 
The Corporacib Sanitiria del Parc Tauli is situated 
in the Vd6s Occidental, a region in Catalonia, north- 
eastern Spain, some 30 km from Barcelona. The area 
has two highly industrialized cities, Sabadell and Terrassa, 
with around 150000 inhabitants each, and outlyng 
rural areas. The population is ethnically homogeneous, 
being composed mainly of Caucasians. The population 
eligible for inclusion in the study were residents in 
the villages and cities in the hospital's referral area: 
according to the 1986-AEC/89 census, the total popu- 
lation of this area is 352266. A sample of 214 patients, 
all of whom had received attention at this hospital 
between September 1994 and January 1995, was 
chosen for the survey. The sample included 165 adults 
undergoing minor surgery, and 49 children seen in the 
Pediatrics Emergency Service. The inclusion criteria 
were: (1) residence in one of the towns in the study 
area; and (2) performance of a blood extraction during 
the medical visit. The sample was stratified according 
to age and in proportion to the study population, as 
reflected in the 1989 Statistics Yearbook of Catalonia, 
based on the 1986 census. Subjects were distributed 
into 10-year age groups, from 0-10 to over-70. Three 
demographic areas were distinguished in each age 
group, according to the total population in the place of 
residence (fewer than 5000 inhabitants was considered 
a rural area, between 5000 and 50000 a semi-urban 
area, and more than 50 000 an urban area). Patients gave 
informed consent to participate, and the hospital's 
Ethics and Research Committee approved the study. 
Sera were frozen at -70°C until analysis. The pre- 
valence of H. pylori infection was studied serologically 
using a commercial ELISA (Pylori Stat Bio Whittaker, 
Walkersville, Md, USA). Following the manufacturer's 
specifications, the result of the test was considered 
positive when the values were superior or equal to 0.20, 
and negative when they were inferior. In the case of 
children under 10, the serology was initially analyzed 
using the same cut-off as for the adults, and sub- 
sequently using a value equivalent to 50% of the adults' 
cut-off point. The serology test was repeated in 70 
samples, chosen at random, and a correlation of 95% 
was obtained. The prevalence of H. pytori infection was 
estimated to be about 70% for the calculation of the 
sample size. The margin for error calculated for 
estimating the prevalence in 214 patients is +6%. 
Comparison of qualitative variables was made by means 
of the chi-square test. The results are expressed as a 
percentage of the total number of patients in each 
group. 
Eighty-three of the 214 patients had positive 
serology for H. pylori and 131 were negative. One 
hundred and eighteen were men (55.1%) and 96 
women (44.8%). The average age was 33. The age 
range was 0-90 years. The overall prevalence of the 
infection was 38.7%. Prevalence increased progressively 
with age, until the 41-50-year age group, in which a 
prevalence of 68.8% was estimated. Prevalence then 
diminished gradually in the older age groups. Only one 
of the patients in the 0-10-year group (n=40) was 
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positive for H. pylori, using both the same point of 
reference as for adults and 50% of this figure as cut-off 
point (Table 1). 
Although a trend towards increased prevalence in 
males was observed, the differences did not reach 
statistical significance: 51 of 118 (43.2%) men were 
positive and 32 of 96 (33.3%) women (p=0.18). 
Differences in prevalence analyzed according to distri- 
bution by demographic area were not significant either: 
51 of 138 (36.9%) in urban areas and 32 of 76 (42.1%) 
in semi-urban or rural areas (p=0.22). 
Our knowledge of the epidemiology of H .  pylori 
infection has progressed rapidly in recent years. There 
are substantial differences in prevalence between 
developed countries (3&50%) and developing countries 
(80-90%), a finding that probably reveals the greater 
ease of transmission in areas with worse hygienic 
conditions [16]. Fecal-oral transmission through drink- 
ing water has been demonstrated in developing 
countries [ 171, and the possibility of oral-oral trans- 
mission in developed countries has been suggested 
118,191. H. pylori infection is usually acquired during 
infancy, and persists for many years. Most infected 
subjects do not present any symptoms; however, 
histologic study reveals chronic type B gastritis in all 
patients with H. pylori infection 1201. The prevalence 
of H .  pylori infection has been correlated with age, 
social class, educational level, and economic and 
hygienic conditions during infancy [16,21,22]. 
In this study, the prevalence of H. pylori infection 
(Table 1) remains low until the age of 20 (<15%), as is 
observed in northern European countries. At this age, 
prevalence increases rapidly, reaching 69% in the 
4 1-50-year age group. This prevalence then tends to 
fall, but remains above 50% in the over-70s. It remains 
unclear whether this fall in prevalence after the age of 
50 reflects a true decrease (either because of spon- 
taneous cure or a cohort effect) or merely a decreased 
sensitivity of serology in detecting H .  pylori infection in 
Table 1 Prevalence (in %) of Helicobartev pylovi infection 
according to age 
Age Patients (n )  Positive (n)  Prevalence (%) 
0-10 
21-30 
11-20 
31-40 
41-50 
51-60 
61-70 
> 70 
40 
28 
34 
25 
32 
23 
15 
17 
1 
4 
12 
13 
15 
8 
9 
97 
1- 
2.5 
14.2 
35.2 
52.0 
68.7 
65.2 
53.3 
52.9 
Total 214 83 38.7 
older subjects. In any case, data concerning age 
distribution should be treated with care, as the number 
of patients in each subgroup is small. Therefore, 
variability in subgroups may be greater than the 6% 
calculated. 
The data currently available are still insufficient to 
establish a reliable map of the prevalence of H. p y h i  
infection in Spain. Only two studies have been designed 
as population studies, i.e. stratifying the sample accord- 
ing to age and sex of the population in the studied area. 
The prevalence observed in our study is similar to that 
reported in the first of these studies, by Rodrigo et al 
1151 in a general population in Asturias, northwestern 
Spain, where 480 sera were studied. The overall pre- 
valence was estimated at 49%, similar to ours, as was 
the distribution according to age. In the paper by 
Carballo et a1 [14], on Guadalajara, a rural area near 
Madrid, in central Spain, 84% of the general population 
had serology that was positive for H. pylori-a far higher 
prevalence than in the rest of the papers published. 
Our  results are comparable with those obtained in 
Barcelona [8 ] ,  Guipuzcoa 1111, Asturias [I51 and 
Madrid 1121, all industrialized areas. Interestingly, the 
studies conducted in Valencia [13] and Alicante [lo], 
and Mallorca 191, all in the southeastern Mediterranean 
area, report a lower prevalence, at least until the 41-50- 
year age group. After this age, the distribution is similar 
to that in the other locations. It is noteworthy that no 
data are available on the prevalence of infection in 
central and southern areas of Spain, and, therefore, 
further studies are required to determine the real 
distribution of H. pylori infection in this country. 
In conclusion, this study suggests that the pre- 
valence of H. pylori infection in our area is higher than 
those generally recorded in developed countries, and 
lower than in developing countries. The low pre- 
valence in the age groups under 30 is closer to the 
pattern of the Western countries, and suggests that a 
progressive decline in diseases secondary to H. pylori 
infection will be observed in the future. In contrast, 
prevalence in the population over the age of 30 is very 
high. This may perhaps be explained by the prolonged 
economic depression after the Spanish Civil War 
(1936-39). 
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Brucellosis is a zoonosis caused by microorganisms of 
the genus Brucella. In Europe, the human disease is 
endemic in Portugal, as it is in countries of the Medi- 
terranean basin [l]. Recognition of acute infection is 
easy when the presentation is typical but, even in 
endemic areas, the varied and sometimes non-specific 
manifestations of the disease may be responsible for 
misdiagnosis of some cases. The diagnosis of the infec- 
tion is established with certainty when brucellae are 
isolated from body tissues or fluids, mainly blood [1,2]. 
Brucella spp. are fastidious microorganisms and, tradition- 
ally, blood cultures should be held for 30 days instead 
of the typical 5-7 days before being discarded as 
negative [3] .  Some modern automatic blood culture 
